Skip to content

Sternal Plating High Risk

Randomized Trial of Rigid Plate Fixation Versus Wire Cerclage in High-Risk Sternotomy Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06660186
Enrollment
250
Registered
2024-10-28
Start date
2026-03-12
Completion date
2027-06-30
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Diseases

Keywords

Cardiac Surgery, Wound Complication, Rigid Sternal Fixation, Sternal Infection, Pain, Non-union

Brief summary

Participants are being invited to participate in a research study at University Hospitals because they have heart disease and are scheduled for open heart surgery. Currently, UH cardiac surgeons close the sternum (or breastbone) after a sternotomy (procedure that allows a doctor to reach the heart and blood vessels) with either a rigid plate fixation Sternal Plate or a Wire Cerclage. However, the study team would like to further evaluate these two techniques. Any volunteer over the age of 18 who is at an increased risk for developing sternal wound complications may be eligible to participate.

Interventions

DEVICERigid Sternal Fixation

The surgeon will close the sternum (breastbone) using the SternalPlate system. The SternalPlate System consists of implants and instruments used to hold the two halves of the sternum together.

The surgeon will close the sternum (breastbone) using Wire Cerclage. Wire Cerclage consists of stainless steel wires used to hold the two halves of your sternum together.

Sponsors

University Hospitals Cleveland Medical Center
Lead SponsorOTHER
Stryker Nordic
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

Preoperative Inclusion Criteria * Adults (age range: 18-89) * Undergoing cardiac surgery through sternotomy -≥2 risk factors: * Diabetes mellitus * Severe COPD * Chronic steroid use * Immunosuppression * Redo sternotomy * Chronic * Kidney disease with GFR \>30 ml/min per 1.73m2 * Radiation therapy * BMI≥35 * High-risk of delirium * Heavy alcohol use Preoperative

Exclusion criteria

* Active malignancy * Chronic narcotic use * NYHA Class IV * Known nickel metal allergy * Compliance concern * eGFR\<30 ml/min per 1.73m2 * Involvement in another interventional clinical trial (non-registry) * Any criteria precluding RPF or WC Operative Inclusion Criteria * Off-midline sternotomy * BITA grafting * CPB time ≥120 minutes * Transverse sternal fracture Operative

Design outcomes

Primary

MeasureTime frameDescription
Sternal healing as measured by CT scan6 months5 axial CT slices from a priori-defined anatomic locations are selected by a radiologist. Two additional radiologists then independently score each location using a 6-point scale (0, 1, 2, 3, 4, or 5) with higher scores representing greater healing. Sternal union will be pre-specified as a mean score ≥3 (total score ≥15).
Number of sternal wound complications as measured by patient/physician report6 monthsSternal wound complications will be a composite of wound dehiscence, sternal dehiscence, SSIs, and DSWIs (synonymous with deep SSIs and mediastinitis).
Total index hospitalization cost6 monthsIndex hospitalization costs (beginning at the time of surgery and ending at initial discharge)
Total cost6 monthsAll costs after initial discharge through 6 months

Secondary

MeasureTime frameDescription
Change in pain as measured by the Wong-Baker pain scalePostoperative days 1, 3, day of discharge (up to 10 days), 1 month, 6 monthsFrom a scale of 0 (no hurts) to 10 (hurts worst)
Change in prescribed narcotic use as measured by patient reportPostoperative days 1, 3, day of discharge (up to 10 days), 1 month, 6 monthsEvaluating mean morphine equivalent
Change in upper extremity functional index (UEFI)Discharge (up to 10 days), 1 month, 6 monthsThe UEFI is a validated 20 item questionnaire used for quantifying UEF in performing normal daily activities.
Change in quality of life as measured by the EuroQol EQ-5D-5LDischarge (up to 10 days), 1 month, 6 monthsThe descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Number of adverse events as measured by patient reportUp to 6 monthsAdverse events of interest not specified above include: damage to soft tissue, organs, or surrounding structures during closure, need for reoperation, loosening of the wires, screws, or plates, fracture of the wires, screws, or plates, and need for hardware removal (wires, screws, or plates).

Countries

United States

Contacts

CONTACTStacey Mazzurco
Stacey.Mazzurco@UHhospitals.org216-844-3130
PRINCIPAL_INVESTIGATORMarc Pelletier, MD

University Hospitals

PRINCIPAL_INVESTIGATORRakesh Arora, MD

University Hospitals

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026